Field test and sensitivity of Onchocerciasis rapid test in Ogun State, Nigeria

Authors

  • O. A. Surakat
  • S. O. Sam-Wobo
  • A. Golden
  • T. De Los Santos
  • M. A. Adeleke
  • D. Faulx
  • K. O. Ademolu
  • S. O. Bankole
  • M. Kalnoky
  • E. Stevens
  • L. Yokobe

Keywords:

Onchocerciasis, diagnosis, IgG4 OV-16 RDT, ELISA, Ogun State, Nigeria

Abstract

Objective: This study, conducted between March 2015 and July 2016, investigated the sensitivity and specificity of the OV-16 RDT and Dried Blood Spot (DBS) Enzyme-Linked Immunosorbent Assay (ELISA) for skin snip microfilaria (MF) detection in Ogun State.

Methods: Five hundred and eighty-eight (588) members of 16 first-line communities in 8 endemic Local Government Areas (LGAs) provided fingerstick whole blood specimens examined for IgG4 antibodies against the O. volvulus antigen OV-16, using DBS OV-16 ELISA and OV-16 RDT. In consort with these specimens, 162 study participants consented to be evaluated by skin snip.

Results: Results showed a seroprevalence of 106(18.0%) using ELISA and 102(17.3%) by RDT, with 92.2% agreement. The OV-16 RDT demonstrated a positive and negative agreement of 76.4 (95% CI 67.2 to 84.1%) and 95.6% (95% CI: 93.4 to 97.3), respectively, to the OV-16 ELISA results from the concordant dataset. Against the 64 positive skin snips microscopy results, sensitivity of the RDT was 79.7% (95% CI 73.43% to 85.27) and the ELISA was 70.3% (95% CI 64.72% to 75.37%).

Conclusion: The results of this study provided information on the performance of the OV-16 RDT. This information will contribute data for comparison to studies in other areas where treatment is ongoing. In conclusion, the commercial launch of the OV-16 RDT has made available a point-of-care diagnostic tool that could serve to help local and country onchocerciasis elimination programs to measure changes and progress in onchocerciasis intervention.

References

Parasites – Onchocerciasis (also known as River Blindness): Onchocerciasis FAQs page. Centers for Disease Control and Prevention website.

A v a i l a b l e a t

https://www.cdc.gov/parasites/onchocerciasis/g en_info/faqs.html). Accessed June 9, 2018.

Zouré HG, Noma M, Tekle AH, Amazigo UV, Diggle PJ, Giorgi E, Remme JH. The geographic distribution of onchocerciasis in the 20 participating countries of the African Programme for Onchocerciasis Control:(2) pre-control endemicity levels and estimated number infected. Parasites & vectors. 2014 Dec;7(1):1-5.

Control of Neglected Tropical Diseases. Guidelines for stopping mass drug administration and verifying elimination of human onchocerciasis. World Health

Organization [Internet]. 2016 Jan 1 [cited 2018

J u n 9 ] ; A v a i l a b l e f r o m :

https://www.who.int/publications/i/item/978924

Accelerating Work to Overcome the Global Impact of Neglected Tropical Diseases: A Roadmap for Implementation. Geneva. World

H e a l t h O r g a n i z a t i o n . Av a i l a b l e athttp://apps.who.int/iris/bitstream/10665/7080

/1/WHO_HTM_NTD_2012.1_eng.pdf.

Accessed 12 January, 2016.

Rodríguez-Pérez MA, Danis-Lozano R, Rodríguez MH, Bradley JE. Comparison of serological and parasitological assessments of Onchocerca volvulus transmission after 7 years of mass ivermectin treatment in Mexico - PubMed. Tropical medicine & international health?: TM & IH. 1999 Feb 1;4(2).

African programme for onchocerciasis control: meeting of National Task Forces. World Health Organization, 2011. Wkly Epidemiol Rec 86: 541-549.

Richards FO, Miri E, Meredith S, Guderian R, Sauerbrey M, Remme H et al. Onchocerciasis. Bulletin of the World Health Organization. 1998;76 Suppl 2:147-149.

Tekle AH, Elhassan E, Isiyaku S, Amazigo UV, Bush S, Noma M, et al. Impact of long-term treatment of onchocerciasis with ivermectin in Kaduna State, Nigeria: first evidence of the potential for elimination in the operational area of the African Programme for Onchocerciasis Control. Parasites & vectors. 2012 Feb 7;5:28.

Mackenzie CD, Homeida MM, Hopkins AD, Lawrence JC. Elimination of onchocerciasis from Africa: possible? Trends in

Parasitology. 2012; 28(1):16–22.doi:

1016/j.pt.2011.10.003.

Sam-Wobo SO, Adeleke MA, Jayeola OA, Adeyi AO, Oluwole AS, Ikenga M, et al.

Epidemiological evaluation of onchocerciasis along Ogun River System, southwest Nigeria - Document - Gale OneFile: Health and Medicine. Journal of Vector Borne Diseases. 2012; 49(2):101–5.

Boatin BA, Toe L, Alley ES, Dembele N, Weiss N and Dadzie KY.Diagnostic in onchocerciasis: Future Challenges, Annals Tropical Medicine and Parasitology. 1998; 92:Suppl 1:S4–S42.

River Blindness Elimination Program page. The Carter Center: Waging Piece. Fighting Disease. Building Hope website. Available at

http://www.cartercenter.org/health/river_blindn ess/index.html. Accessed December 9, 2021.

Lobos E, Weiss N, Karam M, Taylor HR, Ottesen EA, Nutman TB. An immunogenic Onchocerca volvulus antigen: a specific and early marker of i n f e c t i o n . S c i e n c e . 1 9 9 1 M a r

;251(5001):1603-5.

14 Lazzeri M Nutman TB Weiss N, inventors, The United States of America, assignee. Nucleotide molecule encoding a specific Onchocerca volvulus antigen for the immunodiagnosis of onchocerciasis. United States Patent Number 5416009. 1995 May 16.

Feeser KR, Cama V, Priest JW, Thiele EA, Wiegand RE, Lakwo T, et al. Characterizing Reactivity to Onchocerca volvulus Antigens in Multiplex Bead Assays. The American Journal of Tropical Medicine and Hygiene. 2017 Sep

;97(3).

Cama VA, Feleke SM, McDonald C, Wiegand RE, Cantey PT, Arcury-Quandt A, et al. Evaluation of an OV-16 IgG4 Enzyme-Linked Immunosorbent Assay in Humans and Its

Application to Determine the Dynamics of Antibody Responses in a Non-Human Primate Model of Onchocerca volvulus Infection. The American Journal of Tropical Medicine and Hygiene. 2018 Oct 3;99(4):1041–8.

Steel C, Kubofcik J, Ottesen EA, Nutman TB.

Antibody to the Filarial Antigen Wb123 Reflects Reduced Transmission and Decreased Exposure in Children Born following Single Mass Drug

Administration (MDA). PLOS Neglected

Tropical Diseases. 2012 Dec 6;6(12).

Golden A, Stevens EJ, Yokobe L, Faulx D, Kalnoky M, Peck R, et al. A Recombinant Positive Control for Serology Diagnostic Tests Supporting Elimination of Onchocerca volvulus.

PLoS Neglected Tropical Diseases. 2016 Jan 18; 10(1).

.Lipner EM, Dembele N, Souleymane S, Alley WS, Prevots DR, Toe L, et al. Field applicability of a rapid-format anti-Ov-16 antibody test for the assessment of onchocerciasis control measures in regions of endemicity - PubMed. The Journal of infectious diseases. 2006 Jul 15;194(2).

Ogun State Ministry of Health. Ivermectin therapeutic treatmentcoverage records 2014; Unpublished.

Golden, Faulx, Kalnoky, Stevens, Yokobe, Peck, et al. Analysis of age-dependent trends in Ov16 IgG4 seroprevalence to onchocerciasis. Parasites & Vectors. 2016 Jun 13;9(1):1–12.

Surakat OA, Sam-Wobo SO, De Los Santos T,

Faulx D, Golden A, Ademolu K, Yokobe L, Adeleke MA, Bankole SO, Adekunle ON,

Abimbola WA. Seroprevalence of onchocerciasis in Ogun state, Nigeria after ten years of mass drug administration with ivermectin. Southern African Journal of Infectious Diseases. 2018 Nov 1;33(3):65-71.

Fink DL, Fahle GA, Fischer S, Fedorko DF, Nutman TB. Toward molecular parasitologic diagnosis: enhanced diagnostic sensitivity for filarial infections in mobile populations. Journal of clinical microbiology. 2011 Jan;49(1):42-7.

Katabarwa MN, Eyamba A, Nwane P, Enyong P,

Kamgno J, Kueté T, Yaya S, Aboutou R,

Mukenge L, Kafando C, Siaka C. Fifteen years of annual mass treatment of onchocerciasis with ivermectin have not interrupted transmission in the west region of Cameroon. Journal of parasitology research. 2013 Oct;2013.

Evans DS, Alphonsus K, Umaru J, Eigege A, Miri E, Mafuyai H, et al. Status of Onchocerciasis Transmission after More Than a Decade of Mass Drug Administration for Onchocerciasis and Lymphatic Filariasis Elimination in Central Nigeria: Challenges in Coordinating the Stop MDA Decision. PLoS Neglected Tropical

Diseases. 2014 Sep 1;8(9).

Weil GJ, Steel C, LiftisFA.Rapid-format antibody test for diagnosis of onchocerciasis. Journal Infectious Disease. 2000; 182:1796-9.

Golden AL, Faulx D, Yokobe L,Stevens E, Peck R, Valdez M.Criteria for testing development of rapid diagnostic test to support onchocerciasis control and elimination programs. American Journal of Tropical Medicine and Hygiene. 2013; 89(5):82.

Unnasch TR, Golden A, Cama V, Cantey PT. Diagnostics for onchocerciasis in the era of elimination. International Health. 2018 Feb 19;10(suppl_1):i20–6.

Richards Jr FO, Katabarwa M, Bekele F, Tadesse Z, Mohammed A, Sauerbrey M, Dominguez-

Vazquez A, Rodriguez-Perez MA, FernándezSantos NA, Rizzo N, Martínez HR. Operational performance of the Onchocerca volvulus “OEPA” Ov16 ELISA serological assay in mapping, guiding decisions to stop mass drug administration, and posttreatment surveillance surveys. The American Journal of Tropical Medicine and Hygiene. 2018 Sep;99(3):749.

Migchelsen SJ, Martin DL, Southisombath K, Turyaguma P, Heggen A, Rubangakene PP, et al.

Defining Seropositivity Thresholds for Use in Trachoma Elimination Studies. PLOS Neglected Tropical Diseases. 2017 Jan 18;11(1):e0005230.

Golden A, Faulx D, Kalnoky M, Stevens E, Yokobe L, Peck R, Karabou P, Banla M, Rao R, Adade K, Gantin RG. Analysis of age-dependent trends in Ov16 IgG4 seroprevalence to onchocerciasis. Parasites & vectors. 2016 Dec;9(1):1-2.

Oguttu D, Nahabwe C, Unnasch TR,

Byamukama E, Lakwo T, Katabarwa M, et al. Serosurveillance to Monitor Onchocerciasis Elimination: The Ugandan Experience. The American Journal of Tropical Medicine and Hygiene. 2014 Feb 5;90(2):339–45.

Luroni LT, Gabriel M, Tukahebwa E, Onapa AW, Tinkitina B, Tukesiga E, et al. The interruption of Onchocerca volvulus and Wuchereria bancrofti transmission by integrated chemotherapy in the Obongi focus, North Western Uganda. PLOS ONE. 2017 Dec 18;12(12):e0189306.

Lakwo TL, Garms R, Tukahebwa E, Onapa AW, Tukesiga E, Ngorok J, Katamanywa J, Twebaze C, Habomugisha P, Oguttu D, Byamukama E.

Successful interruption of the transmission of

Onchocerca volvulus in Mpamba-Nkusi focus, Kibaale district, mid-western Uganda. East

African Medical Journal. 2015 Dec 3;92(8):4017.

Report of the 1st Meeting of the WHO Onchocerciasis Technical Advisory Subgroup, Varembé Conference Centre, Geneva, Switzerland, 10-12 October 2017. Geneva: World Health Organization; 2017. Licence: CC

BY-NC-SA 3.0 IGO

Downloads

Published

2023-10-11

How to Cite

Surakat, O. A., Sam-Wobo, S. O., Golden, A., De Los Santos, T., Adeleke, M. A., Faulx, D., Ademolu, K. O., Bankole, S. O., Kalnoky, M., Stevens, E., & Yokobe, L. (2023). Field test and sensitivity of Onchocerciasis rapid test in Ogun State, Nigeria. Research Journal of Health Sciences, 11(3), 213–223. Retrieved from https://rjhs.org/index.php/home/article/view/340

Issue

Vol. 11 No. 3 (2023): Research Journal of Health Sciences

Section

Original Article

License

Copyright (c) 2023 Research Journal of Health Sciences

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Research Journal of Health Sciences journal is a peer reviewed, Open Access journal. The Journal subscribed to terms and conditions of Open Access publication. Articles are distributed under the terms of Creative Commons License (CC BY-NC-ND 4.0). (http://creativecommons.org/licences/by-nc-nd/4.0). All articles are made freely accessible for everyone to read, download, copy and distribute as long as appropriate credit is given and the new creations are licensed under the identical terms.